TCL Archive DCBDC Bard Approves Expansion Of SPORE Program To GY Cancers; Okays Two other RFAs December 4, 1992
TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
